Tim Friede
Tracked across 1 events · 7 articles · First seen May 02, 2025 · Last active May 05, 2025
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Tim Friede is the individual who has self-immunized against snake venom, and his blood is being studied for the development of a new antivenom. He is now employed by Centivax.
May 02, 2025 · 7 articles
NEWSDESK
Track Tim Friede live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard